Synapse - Mark Kris

Results (872)

Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay

Meeting Abstract

Arcila, M. E.; Yu, H. A.; Drilon, A. E.; Riely, G. J.; Zehir, A.; Sadowska, J.; Hyman, D. M.; Kris, M. G.; Berger, M. F.; Ladanyi, M.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Journal Article

Sholl, L. M.; Aisner, D. L.; Varella-Garcia, M.; Berry, L. D.; Dias-Santagata, D.; Wistuba, I. I.; Chen, H.; Fujimoto, J.; Kugler, K.; Franklin, W. A.; more...
Journal of Thoracic Oncology (2015)

Fulltext@MSK | Save

Phase I/II study of HSP90 inhibitor AUY922 and Erlotinib for EGFR-Mutant lung cancer with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors

Journal Article

Johnson, M. L.; Yu, H. A.; Hart, E. M.; Weitner, B. B.; Rademaker, A. W.; Patel, J. D.; Kris, M. G.; Riely, G. J.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas

Journal Article

Yu, H. A.; Sima, C. S.; Hellmann, M. D.; Naidoo, J.; Busby, N.; Rodriguez, K.; Riely, G. J.; Kris, M. G.
Cancer (2015)

Fulltext@MSK | Save

Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas

Journal Article

Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S.; Gainor, J.; Shaw, A.; Hames, M.; Iams, W.; Aston, J.; Lovly, C. M.; more...
Journal of Thoracic Oncology (2015)

Fulltext@MSK | Save

MAP2K1 (MEK1) mutations define a distinct subset of lung adenocarcinoma associated with smoking

Journal Article

Arcila, M. E.; Drilon, A.; Sylvester, B. E.; Lovly, C. M.; Borsu, L.; Reva, B.; Kris, M. G.; Solit, D. B.; Ladanyi, M.
Clinical Cancer Research (2015)

Fulltext@MSK | Save

Comprehensive assessment of targetable driver alterations in lung adenocarcinomas using a clinical, hybrid capture-based, next-generation sequencing assay

Meeting Abstract

Arcila, M.; Zehir, A.; Cheng, D.; Yu, H.; Kris, M.; Drilon, A.; Riely, G.; Berger, M.; Ladanyi, M.
Modern Pathology (2015)

Fulltext@MSK | Save

Comprehensive assessment of targetable driver alterations in lung adenocarcinomas using a clinical, hybrid capture-based, next-generation sequencing assay

Meeting Abstract

Arcila, M.; Zehir, A.; Cheng, D.; Yu, H.; Kris, M.; Drilon, A.; Riely, G.; Berger, M.; Ladanyi, M.
Laboratory Investigation (2015)

Fulltext@MSK | Save

Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium

Journal Article

Villaruz, L. C.; Socinski, M. A.; Abberbock, S.; Berry, L. D.; Johnson, B. E.; Kwiatkowski, D. J.; John Iafrate, A.; Varella-Garcia, M.; Franklin, W. A.; Camidge, D. R.; more...
Cancer (2015)

Fulltext@MSK | Save

Chemotherapy for lung cancers: Here to stay

Journal Article

Kris, M. G.; Hellmann, M. D.; Chaft, J. E.
American Society of Clinical Oncology Educational Book (2014)

Fulltext@MSK | Save